Reminder: Invitation to Roche ’s virtual ESG event: Access to Healthcare

We are pleased to invite investors and analysts to participate in our virtual event onMonday, 16 May 2022, presenting Roche ’s access to healthcare strategy highlighting initiatives from both the Diagnostics and Pharmaceuticals divisions.15:00 – 16:30 CEST / 14:00 - 15:30 BST09:00 – 10:30 am EDT / 6:00 – 7:30 am PDTThe webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 14:00 CEST on the day of the event.>click hereAgendaWelcomeBruno Eschli, Head of Investor RelationsRoche Sustainability StrategyPascale Schmidt, Chief Compliance and Sustainability OfficerHow Roche Diagnostics enables access to healthcareThomas Schinecker, CEO Roche DiagnosticsDriving Access to Diagnostics across the Globe Stefan Seliger, Head Global Access& Policy, Diagnostics DivisionDriving Access to Medicine across the GlobeMichael Oberreiter, Head Global Access, Pharmaceuticals DivisionQ&AAccess to virtual event (pre-registration required)Please pre-register for our webinarhere*.Should you be unable to register for the webinar due to your company IT policy, please send an e-mail [e-mail].A replay of the webcast will be available via>ir.roche.com*privacy noticeBest regards, Bruno Eschli Head of Investor Relations   Roche Investor Relations Dr. Bruno EschliPhone: [phone]e-mail:[e-mail] Dr. Sabine Borngr äberPh...

Source: Roche Investor Update - May 9, 2022 Category: Pharmaceuticals Source Type: news